Silence Therapeutics To Receive $2M Research Milestone Payment From Hansoh Pharma, Following The Achievement Of A Second Undisclosed Milestone Related To The First Target Under The Collaboration
Silence Therapeutics To Receive $2M Research Milestone Payment From Hansoh Pharma, Following The Achievement Of A Second Undisclosed Milestone Related To The First Target Under The Collaboration
翰森製藥將向Silence Therapeutics支付200萬美元的研究里程碑費用，以此慶祝在合作的第一目標下達成第二個未公開里程碑。
Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company committed to transforming peoples' lives by silencing diseases through precision engineered medicines, today announced that it will receive a $2.0 million cash payment from Hansoh Pharmaceutical Group Company Limited ("Hansoh") following the achievement of a second undisclosed milestone related to the first target under the collaboration
Silence Therapeutics plc，納斯達克：SLN（以下簡稱“Silence”或“公司”），一家經驗豐富且創新的生物技術公司，致力於通過精密設計的藥物來沉默疾病，改善人們的生活。今天宣佈，在與漢賽藥業集團有限公司（以下簡稱“漢賽藥業”）合作下，公司完成了與其合作的第一個目標的第二項不公開里程碑，將收到200萬美元的現金支付。